Profile of the three Phase III studies included in both the efficacy and safety analyses. (DOCX 47.4 KB
Table S1. The Severity Scale of asthma patients in the Guidelines for Prevention and Treatment of Br...
Scatter plot of ACQ and miniAQLQ scores. Table S1. Characteristics of asthma. Table S2. Lung functio...
Scoring for severity of asthma modified by Eisnerâs method. Table S2: Pearson correlation coeffici...
Profile of the two additional Phase IIb studies included in only the safety analyses. (DOCX 25.6 KB
Adjusted treatment differences from baseline in trough FEV1 at Week 12 (Efficacy population). (DOCX ...
AEs reported by âĽ3 patients in the Japan+Korea cohort of any relevant treatment arm and the corres...
List of Institutions and Independent Ethics Committees/Institutional Review Boards for Studies HZA10...
Region ratios of ‘treatment effect’ in Japan+Korea and Not-Japan+Korea patients, where ‘treatment ef...
Summary of the most common adverse events (âĽ5%) in the Asian and non-Asian populations. (DOCX 24 k...
Asthma quality of life questionnaire score (pooled data) in Asian and non-Asian patients, at baselin...
Supplementary appendix: The anti-inflammatory duration of action of fluticasone furoate/vilanterol t...
e-table 1: Characteristics of the studies and treatment arms included in the MTC. e-table 2: Results...
Flowchart of the study population. Detailed information on characteristics and co-medication of case...
Consolidated Standards of Reporting Trials (CONSORT) 2010 checklist of information to include when r...
Study design Figure. Abbreviations: BDI, Baseline Dyspnoea Index; CAT, COPD Assessment Test; FP/SAL,...
Table S1. The Severity Scale of asthma patients in the Guidelines for Prevention and Treatment of Br...
Scatter plot of ACQ and miniAQLQ scores. Table S1. Characteristics of asthma. Table S2. Lung functio...
Scoring for severity of asthma modified by Eisnerâs method. Table S2: Pearson correlation coeffici...
Profile of the two additional Phase IIb studies included in only the safety analyses. (DOCX 25.6 KB
Adjusted treatment differences from baseline in trough FEV1 at Week 12 (Efficacy population). (DOCX ...
AEs reported by âĽ3 patients in the Japan+Korea cohort of any relevant treatment arm and the corres...
List of Institutions and Independent Ethics Committees/Institutional Review Boards for Studies HZA10...
Region ratios of ‘treatment effect’ in Japan+Korea and Not-Japan+Korea patients, where ‘treatment ef...
Summary of the most common adverse events (âĽ5%) in the Asian and non-Asian populations. (DOCX 24 k...
Asthma quality of life questionnaire score (pooled data) in Asian and non-Asian patients, at baselin...
Supplementary appendix: The anti-inflammatory duration of action of fluticasone furoate/vilanterol t...
e-table 1: Characteristics of the studies and treatment arms included in the MTC. e-table 2: Results...
Flowchart of the study population. Detailed information on characteristics and co-medication of case...
Consolidated Standards of Reporting Trials (CONSORT) 2010 checklist of information to include when r...
Study design Figure. Abbreviations: BDI, Baseline Dyspnoea Index; CAT, COPD Assessment Test; FP/SAL,...
Table S1. The Severity Scale of asthma patients in the Guidelines for Prevention and Treatment of Br...
Scatter plot of ACQ and miniAQLQ scores. Table S1. Characteristics of asthma. Table S2. Lung functio...
Scoring for severity of asthma modified by Eisnerâs method. Table S2: Pearson correlation coeffici...